Peer Science > Webcasts >

Open Genomics Webcasts

Open Webcasts
Addition of Triton X-102 to Wash Buffers for the miRNA and Gene Expression Microarray Applications
Stephanie Fulmer-Smentek, Ph.D., RNA Applications R&D Group Manager, Agilent Technologies
Watch Webcast Now

About this Series
Welcome to the Open Genomics Webcast series, where your peers discuss their latest findings in Genomics research. These Webcasts are designed to be informative, technical presentations of how scientists are charting their own course to find answers to biological questions. Each Webcast provides a 15-20 minute presentation by a researcher sharing recent findings through pertinent data. We hope you will see these Webcasts as one channel for staying current in the latest research in genomics.

Other Webinars


Gene Expression
Post-Genomics of the Model Archaeon Halobacterium sp. NRC-1
Dr. Shiladitya DasSarma, University of Maryland Biotechnology Institute and Greenebaum Cancer Center, University of Maryland.
More

Customized Oligonucleotide Microarray Gene Expression-Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification
Dr. Andre Oberthuer, MD, Cologne Children's Hospital, Department of Pediatric Oncology and Hematology.
More

Identification of Candidate Genetic Modifiers of Susceptibility to Skin Tumor Promotion in Mouse Epidermis
Penny K. Riggs, PhD, The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, TX.
More

Addition of Triton X-102 to Wash Buffers for the miRNA and Gene Expression Microarray Applications
Stephanie Fulmer-Smentek, Ph.D., RNA Applications R&D Group Manager, Agilent Technologies
More

RNA Quality in Frozen Breast Cancer Samples and the Influence on Gene Expression Analysis
Carina Strand, Lund University, Department of Oncology, Lund, Sweden
More


miRNA
Direct miRNA Profiling from Low Input Total RNA
Hui Wang, PhD, Agilent Technologies.
More

Methylation
MIRA-Assisted Microarrays for DNA Methylation Analysis and Cancer Diagnosis
Dr. Gerd P. Pfeifer, Beckman Research Institute, City of Hope, Duarte, California.
More

ChIP-on-chip
Transcriptional Regulation of Eukaryotic Genomes
Dr. Richard Young, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology.
More

Regulation of Eukaryotic Transcription by the ETS Family of Transcription Factors
Dr. Barbara Graves, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
More

A Chromatin Landmark and Transcription Initiation at Most Promoters in Human Cells
Dr. Richard Young, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology.
More

Protein Network Comparative Genomics
Dr. Trey Ideker, University of California San Diego, 4th Annual Cytoscape Workshop.
More

New Connections Between Signal Transduction and Transcriptional Regulatory Circuitry
Dr. Richard Young, Whitehead Institute for Biomedical Research; Massachusetts Institute of Technology.
More


Oligo aCGH
Genomic and Expression Profiling Further Defines the Molecular Features of Intrachromosomal Amplification of Chromosome 21 in Acute Lymphoblastic Leukaemia
Jon C. Strefford PhD, Leukaemia Research-Cytogenetics Group, University of Southampton.
More

Influence of Genome-Wide DNA Alteration on Expression in Breast Carcinomas
Dr. Anne-Lise Borresen-Dale, Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway.
More

Genomic disorders: The genomic basis of disease and clinical implementation of high resolution genome analysis
James R. Lupski, M.D., Ph.D., Department of Molecular and Human Genetics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas
More

Genomic Alterations in Early Colorectal Cancer
Dr. Michael Bittner, Co-Director and Senior Investigator, Translational Genomics Research Institute.
More

The Cryptic Chromosomal Deletion
Dr. Jules Meijerink, Department of Pediatric Oncology, Erasmus MC, Rotterdam, The Netherlands.
More

Dissecting Genomic Changes by CGH Arrays in Hematological Malignancies
Dr. Juan C. Cigudosa, Director of the Human Cytogenetics Laboratory, CNIO (Centro Nacional de Investigaciones Oncologicas) Madrid, Spain.
More

CGH Analytics Tutorial
Drs. Maryam Fazad and Paco Cifuentes, Agilent Technologies.
More

Oncogenomic Analyses of Mouse and Human Tumors
Dr. Lynda Chin, Harvard Medical School, Dana-Farber Cancer Institute.
More

Genomic Imbalances in the Cancer Genome
Nallasivam Palanisamy Ph.D., Group Leader, Cancer Biology, Genome Institute of Singapore, Singapore
More

aCGH Identifies Genome Imbalances
Dr. Paola Scaruffi, National Institute for Cancer Research (IST) Genoa, Italy.
More

Interpreting the Consequences of Gene Gain and Loss
Dr. Michael Bittner, Translational Genomics Research Institute (TGen).
More

Defining the Dynamic Changes in Cancer Genomes by Integrating Array Comparative Genomic Hybridization (aCGH) Findings with Molecular Cytogenetic Data
Jeremy Squire Ph.D., Senior Scientist, Ontario Cancer Institute.
More

The fine-scale and complex architecture of human CNV regions as defined by custom high-density oligonucleotide microarrays
Anya Tsalenko, Ph.D.
Life Science and Nanotechnology Department, Agilent Laboratories
More

High resolution CGH analysis of genomic copy number variation in 50 healthy Caucasian adult males
Dr. Alexandra I. F. Blakemore, Imperial College, London
More

Dr. Jeff Gregg on CGH Genome Arrays: The Use and Applications in Autism and Neurodevelopmental Disorders
Dr. Jeff Gregg, University of California at Davis Department of Pathology and the M.I.N.D. Institute.
More

Probe and Array Design for the Agilent CGH Platform
Peter Webb, Agilent Technologies.
More

Clinical Utility of Array CGH from Paraffin Embedded Tissue
Dr. Jeff Gregg, M.D., University of California at Davis Department of Pathology and the M.I.N.D. Institute.
More


Other/Multiple
RNA Integrity Database (RINdb)- Bioanalyzer RNA Profiles
Marc Valer, Microfluidics Program Manager, Genomics, Agilent Technologies, Santa Clara.
More

Mulitplex Capture of Large Sets of Human Exons
Jay Shendure, MD, PhD, Department of Genome Sciences, University of Washington.
More